Sean Ellis

Insider Reports History

Location
Jerusalem, Israel
Signature
/s/ Dana Yaacov-Garbeli, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sean Ellis:

Company Role Class Num Shares Value Price $ Report Date Ownership
Entera Bio Ltd. Director Ordinary Shares, par value NIS 0.0000769 per share 160,098 $382,634 $2.39 01 Jan 2026 Direct
Entera Bio Ltd. Director Stock Option (right to buy) 33,505 01 Jan 2026 Direct

Insider Reports Filed by Sean Ellis

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ENTX Entera Bio Ltd. 01 Jan 2026 2 $0 4 Director 02 Jan 2026, 16:25
ENTX Entera Bio Ltd. 15 Jan 2025 2 $0 4 Director 17 Jan 2025, 16:30
ENTX Entera Bio Ltd. 02 Oct 2024 1 $0 4 Director 04 Oct 2024, 16:05
ENTX Entera Bio Ltd. 27 Aug 2024 1 $0 4 Director 29 Aug 2024, 16:50
ENTX Entera Bio Ltd. 01 Jan 2024 1 $0 4 Director 03 Jan 2024, 16:11
ENTX Entera Bio Ltd. 21 Aug 2023 1 +$24,000 4 Director 22 Aug 2023, 09:20
ENTX Entera Bio Ltd. 02 Jan 2023 1 $0 4 Director 04 Jan 2023, 15:05
ENTX Entera Bio Ltd. 11 Nov 2022 1 +$15,900 4 Director 14 Nov 2022, 08:17
ENTX Entera Bio Ltd. 21 Jul 2022 1 +$24,406 4 Director 25 Jul 2022, 17:19
ENTX Entera Bio Ltd. 18 Jan 2022 0 $0 4/A Director 25 Jul 2022, 17:21
ENTX Entera Bio Ltd. 01 Jan 2022 0 $0 3/A Director 25 Jul 2022, 17:23
ENTX Entera Bio Ltd. 01 Jan 2022 2 $0 4 Director 14 Jan 2022, 15:04